BCG strain Danish

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

Tuberculosis

Phase 1

BCG Vaccination Delivered Intradermally, Orally and by Combined Routes

CompletedNCT00396370

National Institute of Allergy and Infectious Diseases (NIAID)Tuberculosis

Start: 2008-12-02End: 2012-07-23Updated: 2019-11-12

Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

CompletedNCT01119521

National Institute of Allergy and Infectious Diseases (NIAID)Tuberculosis

Start: 2010-10-31End: 2013-07-31Updated: 2017-01-09

Related Papers

MR1-Independent Activation of Human Mucosal-Associated Invariant T Cells by Mycobacteria

The Journal of Immunology2019-10-1468 citations

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease

PLoS Pathogens2017-11-16241 citations

Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.

2014-05-0929 citations

Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study.

2014-03-0128 citations